Found: 20
Select item for more details and to access through your institution.
Emerging Efficacy Endpoints for Targeted Therapies in Advanced Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2006, v. 20, p. 19
- By:
- Publication type:
- Article
Endobronchial metastases from renal cell carcinoma: A late manifestation of the disease with an increasing incidence.
- Published in:
- BJU International, 2012, v. 110, n. 10, p. 1407, doi. 10.1111/j.1464-410X.2012.11442.x
- By:
- Publication type:
- Article
Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.
- Published in:
- BJU International, 2011, v. 108, n. 8, p. 1279, doi. 10.1111/j.1464-410X.2010.09990.x
- By:
- Publication type:
- Article
Establishing the role of cytokine therapy in advanced renal cell carcinoma.
- Published in:
- BJU International, 2008, v. 101, n. 9, p. 1063, doi. 10.1111/j.1464-410X.2008.07435.x
- By:
- Publication type:
- Article
The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.
- Published in:
- Journal of Pathology, 1995, v. 176, n. 2, p. 167, doi. 10.1002/path.1711760210
- By:
- Publication type:
- Article
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
- Published in:
- Nature Genetics, 2010, v. 42, n. 10, p. 874, doi. 10.1038/ng.668
- By:
- Publication type:
- Article
Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstruction.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 1999, v. 106, n. 9, p. 964, doi. 10.1111/j.1471-0528.1999.tb08438.x
- By:
- Publication type:
- Article
A uthors' R eply.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 1996, v. 103, n. 2, p. 185, doi. 10.1111/j.1471-0528.1996.tb09678.x
- By:
- Publication type:
- Article
Ovarian cancers related to minimal access surgery.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 1995, v. 102, n. 9, p. 726, doi. 10.1111/j.1471-0528.1995.tb11431.x
- By:
- Publication type:
- Article
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
- Published in:
- 1999
- By:
- Publication type:
- journal article
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Sunitinib in the treatment of metastatic renal cell carcinoma.
- Published in:
- Therapeutic Advances in Urology, 2016, v. 8, n. 6, p. 348, doi. 10.1177/1756287216663979
- By:
- Publication type:
- Article
Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study.
- Published in:
- BJU International, 2017, v. 119, n. 6, p. 846, doi. 10.1111/bju.13740
- By:
- Publication type:
- Article
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 85, p. 1, doi. 10.1126/scitranslmed.3002004
- By:
- Publication type:
- Article
A monoclonal antibody which differentiates between bound and free human secretory component.
- Published in:
- European Journal of Immunology, 1984, v. 14, n. 4, p. 344, doi. 10.1002/eji.1830140413
- By:
- Publication type:
- Article
Sunitinib in metastatic renal cell carcinoma patients with brain metastases.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 3, p. 501, doi. 10.1002/cncr.25452
- By:
- Publication type:
- Article
The melanocortin receptor agonist NDP-MSH impairs the allostimulatory function of dendritic cells.
- Published in:
- Immunology, 2010, v. 129, n. 4, p. 610, doi. 10.1111/j.1365-2567.2009.03210.x
- By:
- Publication type:
- Article
Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies.
- Published in:
- Oncologist, 2010, v. 15, n. 11, p. 1135, doi. 10.1634/theoncologist.2010-0078
- By:
- Publication type:
- Article
Response: Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1558, doi. 10.1093/jnci/djr329
- By:
- Publication type:
- Article
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 9, p. 763, doi. 10.1093/jnci/djr128
- By:
- Publication type:
- Article